Menu Menu


/ News
Friday, 1st July 2022 | 11,498 veterinary jobs online | 88 people actively seeking work | 5,210 practices registered

Veterinary Industry News

Send us your news

VRCC To Participate In Clinical Trial Evaluating The Efficacy Of A New Drug To Treat Dogs With Inoperable Grade 2 & 3 Mast Cell Tumours

13 years ago

20th May, 2009 00h00

VRCC is participating in a ‘Clinical Trial’ evaluating the efficacy of a New Drug to treat Dogs with inoperable Grade 2 & 3 Mast Cell Tumours VRCC offers all the most modern treatments for Dogs with Mast Cell Tumours but this ‘Trial’ treatment is now available at VRCC for Dogs where current treatment may not be appropriate or where clients do not or are unable to pursue the conventional route. For full details contact: Beatriz Balana Tapia or Dr Susan North at: VRCC Veterinary Referrals No1 Bramston Way Southfields. Laindon. Essex. SS15 6TP Te: 01268 564664

More from